https://www.selleckchem.com/products/gw3965.html
Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is an effective alternative to HLA-matched transplantation. However, Epstein-Barr virus (EBV) infection causes morbidity and mortality in patients undergoing haplo-HSCT. Here, we retrospectively evaluated the incidence and risk factors of EBV-DNAemia and EBV-associated diseases in 131 patients who underwent haplo-HSCT. Patients were classified into the no-EBV infection group, EBV-DNAemia group, and EBV-associated disease group. Cumulative in
Gefällt mir
Kommentar
Teilen
